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Microenvironment-targeted therapies are emerging as possible complementary 
approaches to treat malignancies. However, progress is hindered by the 
complexity of the interactions between malignant cells and their 
microenvironment. In leukemia, this complexity is further emphasized by a 
highly dynamic behavior of leukemic cells recently reported in Nature. Hawkins, 
Duarte and colleagues analyze leukemic cell localization relative to 
microenvironmental cells in T-cell acute lymphoblastic leukemia (T-ALL) 
through real-time intravital imaging1. Contrasting previous studies, Lo Celso and 
colleagues report a highly motile behavior and lack of stable interactions with 
specific microenvironmental cell types during disease progression or after 
chemotherapy. This study challenges some current concepts on 
microenvironmental dependence of leukemia. 
 
Leukemic cells migrate throughout the body, then identify and seed suitable 
territories where they can expand. Cumulative evidence suggests that the 
support of the bone marrow (BM) microenvironment is required for leukemia 
initiation, progression or resistance to therapy. In some cases leukemic cells 
compete with their normal counterparts for the most permissive/supportive 
areas, since similar microenvironmental requirements have been proposed for 
normal hematopoietic stem cells (HSCs) and leukemia initiating cells (LIC)2.  
In a previous study, Lo Celso and colleagues developed powerful intravital 
microscopy methods which revealed that normal HSCs transplanted into 
irradiated mice (to stimulate BM homing) steadily locate near bone-forming cells 
(osteoblasts)3. Osteoblasts also promote T cell development by providing the 
Notch ligand DLL44. In non-irradiated mice, HSCs have been preferentially found 
near their niche cells, such as endothelial cells5 and their associated BM 
mesenchymal stem cells (BMSCs)6. Hawkins, Duarte and colleagues take these 
notions further and use their optimized intravital microscopy to study leukemia 
and particularly the spatial relationships of T-acute lymphoblastic leukemia (T-
ALL) cells with osteoblasts, nestin-GFP+ cells (marking BMSCs)6 and endothelial 
cells. 
Briefly, the position of transplanted T-ALL cells relative to osteoblasts, nestin-
GFP+ cells and endothelium was recorded during 3-hour imaging sessions. 
Different time points after transplantation reflected various stages of leukemia 
development. A time-lapse study was performed after treatment with 
conventional chemotherapy to study the localization, division and migratory 
behavior of chemo-resistant T-ALL cells. This is an impressive effort that has 
provided the first extensive analysis of real-time leukemic cell positioning and 
migration within BM niches. A major novel finding is that T-ALL cells (either 
before or after chemotherapy) seem to be highly motile and lack any apparent 
localization preference within BM (Figure 1). The authors envision that targeting 
the interactions with microenvironmental cells (rather than specific cell types) is 
more likely to succeed therapeutically. 
One key interaction of T-ALL cells with their BM microenvironment is mediated 
by the chemokine Cxcl127-9, highly expressed by nestin+ BMSCs, followed by 
osteoblasts and endothelial cells6. Two previous studies7, 8 demonstrated that T-
ALL cells require microenvironmental Cxcl12 for their BM lodgment and also for 
disease progression. Accordingly, increased cell surface expression of the Cxcl12 
receptor Cxcr4 was found in T-ALL cells. It is possible that the dynamic behavior 
and heterogeneous Cxcr4 expression in T-ALL found by Lo Celso et al, together 
with different and variable Cxcl12 levels in the studied niche cells (nestin+ 
BMSCs>osteoblast & endothelial cells), might have masked some cell-type-
specific interactions at the whole population level.  
Whereas the study by Lo Celso’s group does not show significant proximity of T-
ALL cells to these Cxcl12-producing cells, the studies by Passaro, Pitt and 
colleagues7, 8 indicated cell-type-specific functional dependency of T-ALL. It is 
worth pointing out that proximity-based studies have revealed important 
regulators of HSC and progenitor function3, 5, 6, 10 but have not always correlated 
with function in the aforementioned T-ALL studies. One example of discrepancy 
between proximity and function is found in the study by Passaro et al, where 
almost all T-ALL cells localized close to Lepr-traced mesenchymal cells (largely 
overlapping with nestin+ BMSCs) but Cxcl12 deletion in these cells did not affect 
T-ALL development. In contrast, endothelial Cxcl12 deletion rendered animals 
virtually disease-free, while only 70% of T-ALL cells appeared to locate near 
endothelial cells8.  
Observations made at different time points during disease development suggest 
that time scale might underlie discrepant conclusions and also preclude accurate 
comparisons across these studies. Whereas Passaro et al and Pitt et al focused on 
long-term effects and demonstrated that microenvironmental Cxcl12 is essential 
for T-ALL progression, the study by Lo Celso’s group is mainly focused on 
imaging the early disease, starting from day 10 after transplanting T-ALL cells. It 
is possible that a posterior selection process might favor the expansion of 
Cxcl12-dependent clones sustaining the disease in the long term. In this regard, 
transformation of hematopoietic progenitors to T-ALL cells progresses through a 
phase of expansion of pre-leukemic clones driven by Notch signaling, and it has 
been suggested that disease progression requires further selection11. 
Importantly, although the three studies analyzed Notch-mutated T-ALL models, 
the mutations were different, leading to various kinetics and morbidity. The 
disease was comparatively less aggressive in the model used by Lo Celso’s 
group12. Therefore, the microenvironmental dependence might also be less 
obvious than in the other studies, in which aggressive hijacking of the normal 
environment appeared to be required for leukemogenesis.  
Another pioneering contribution from Hawkins, Duarte and colleagues is the 
visualization of T-ALL cells in the same mice before and after administration of 
different chemotherapy regimens. Unexpectedly, T-ALL cells increased their 
migratory activity upon administration of dexamethasone or vincristine and did 
not preferentially locate near osteoblasts or nestin-GFP+ cells. The lack of 
sustained physical interactions with these niche cells made the authors 
hypothesize that T-ALL cells surviving chemotherapy do not require protective 
effects from the BM stroma. Remarkably, quiescence was not a hallmark of 
surviving T-ALL cells, since intense proliferation was observed immediately after 
chemotherapy. 
On a broader scale, migration-related gene transcripts (including Cxcr4) were 
not differentially expressed by T-ALL cells before and after chemotherapy, 
raising the possibility that the dynamic interactions with the microenvironment 
might be guided by fast-acting changes in cell surface receptors, affecting for 
instance Cxcr4 recycling7 or activation status. Increased Cxcr4 expression and 
migratory behavior was also observed by the Lo Celso group in HSCs after 
infection13, suggesting potential commonalities that might facilitate the 
identification of new underlying mechanisms. 
Altogether, the results from these studies argue for both key cell-autonomous 
mechanisms and promiscous/varied interactions with niche cells driving T-ALL 
invasion in BM which, as a Cxcl12-enriched environment, remains a favorite 
territory for T-ALL development. Further analysis of T-ALL cell trajectories 
during disease evolution might help to understand whether T-ALL cells 
stochastically migrate and interact with microenvironmental cells or whether 
specific patterns and selection occur driven by yet undefined stimuli. 
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Figure 1. A simple representation of highly dynamic T-ALL behavior. Polarized 
cell shape illustrates high T-ALL motility while arrows pointing in different 
directions highlight lack of specificity in T-ALL positioning towards the 
presented HSC niche cells. T-ALL, T-cell acute lymphoblastic leukemia; HSC, 
hematopoietic stem cell; BMSC, bone marrow mesenchymal stem cell. 
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